⟵ Back to Search Results
BGB-A317-204

Completed

Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

Beigene Study ID info

BGB-A317-204

ClinicalTrials.gov ID info

NCT04004221

China Drug Trials ID info

CTR20170071

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan